Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 4, 2025

Supplementary Figures S1-S10 from Detection of Brain Cancer Using Genome-wide Cell-free DNA Fragmentomes

View Full Paper
Ask AI
Bookmark
Share

Authors

DMDimitrios MathiosNNNoushin NiknafsAAAkshaya V. Annapragada

Discussion

Loading...

Member takes

Overview

Supplementary figures illustrate the ARTEMIS-DELFI model's effectiveness in predicting brain cancer outcomes and its correlation with tumor characteristics.

Key Points

  • The study presents ARTEMIS-DELFI, a model predicting brain cancer based on genome-wide cell-free DNA analysis.
  • Correlation is observed between ARTEMIS-DELFI scores and Ki-67 proliferation indices in tumor samples.
  • Feature importance is highlighted, showing how various genomic factors contribute to brain cancer predictions.
  • These findings underline the potential of ARTEMIS-DELFI in improving brain cancer diagnosis and management.

Cite This Study

Mathios et al. (2025) studied this question.

synapsesocial.com/papers/689a0f86e6551bb0af8d0949https://doi.org/10.1158/2159-8290.29819623
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Abstract 3695: Monitoring response to immunotherapy using cell free DNA fragmentomes2024
  2. 2Knowledge-informed multimodal cfDNA analysis improves sensitivity and generalization in cancer detection2025 · 3 citations
  3. 3Abstract 5325: Cell-free DNA fragmentomes for treatment response monitoring in patients with metastatic colorectal cancer: The Dolphin study.2026
  4. 4Cell-free DNA fragmentomics and methylomics for thymic epithelial tumors.2026
  5. 5Integrated machine learning analysis of 30 cell death patterns identifies a novel prognostic signature in glioma2025 · 1 citations